SQZ Biotechnologies develops cell therapies that harness the body’s natural immune system to combat disease. The Company primarily focuses on preclinical immuno-therapy programs in oncology and other serious diseases. It develops CellSqueeze, a technology platform for engineering various cell functions for therapeutic applications.
|Employees (est.) (Oct 2020)||104||(-6%)|
SQZ Biotech total Funding
SQZ Biotech latest funding size
Time since last funding
|5 months ago|
SQZ Biotech investors
|Polaris Partners, Temasek Holdings, MassChallenge, Invus, NanoDimension, Maine Angels, GV, JDRF T1D Fund, Quark Venture, Illumina Ventures, Everblue, Orient Life, Viva Ventures Biotech Group, Bridger Healthcare Partners, Global Health Science Fund, Polaris|
SQZ Biotech has 416 Twitter Followers. The number of followers has increased 3% month over month and increased 4.4% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was SQZ Biotech founded?
SQZ Biotech was founded in 2013.
Who are SQZ Biotech key executives?
SQZ Biotech's key executives are Armon Sharei, Teri Loxam and Oliver Rosen.
How many employees does SQZ Biotech have?
SQZ Biotech has 104 employees.
Who are SQZ Biotech competitors?
Competitors of SQZ Biotech include PamBio, Metacrine and Fulcrum Therapeutics.
Where is SQZ Biotech headquarters?
SQZ Biotech headquarters is located at 200 Arsenal Yards Blvd, Watertown.
Where are SQZ Biotech offices?
SQZ Biotech has an office in Watertown.
How many offices does SQZ Biotech have?
SQZ Biotech has 2 offices.
Receive alerts for 300+ data fields across thousands of companies